Last reviewed · How we verify
NCT03437772: Hyper-mCBT
Third Generation Cognitive Behavioural Therapy vs Treatment-as-usual for ADHD
trial testing Mindfulness Cognitive Behavioral Therapy program in Adhd in 248 participants. Completed in 23 November 2022.
23 November 2022
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Nīmes |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 248 |
| Start date | 19 February 2018 |
| Primary completion | 23 November 2022 |
| Estimated completion | 23 November 2022 |
| Sites | 4 locations across France |
Drugs / interventions tested
- Mindfulness Cognitive Behavioral Therapy program
Conditions studied
- Adhd — all drugs for Adhd →
Sponsor
Centre Hospitalier Universitaire de Nīmes
Who can join
Adults 7 to 15, any sex, with Adhd. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators hypothesize that the mindfulness Cognitive Behavioral Therapy program will lead to a reduction in attention deficit and hyperactivity disorder symptoms, anxiety and depression, and improve self-confidence, emotional control, social integration and school results.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Third-generation cognitive behavioral therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a multicenter randomized controlled trial.
Crouzet L, Gramond A, Suehs C, Fabbro-Peray P, et al · · 2022 · cited 8× · PMID 35090544 · DOI 10.1186/s13063-021-05983-2 -
Third generation cognitive behavioural therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a randomized, 2-parallel-group, evaluator blinded, superiority trial
Crouzet L, Gramond A, Suehs C, Fabbro-Peray P, et al · · 2021 · DOI 10.21203/rs.3.rs-462948/v1
Verify or expand the search:
- PubMed search for NCT03437772
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Adhd
Currently open trials in the same condition.
- NCT03672266 — Studies of Brain and Body Interaction · recruiting
Other Centre Hospitalier Universitaire de Nīmes trials
Trials by the same sponsor.
- NCT07403474 — Combined Use of a Respiratory Multiplex PCR and Algorithm-based Therapy to Improve Early Optimization of Antibiotic Ther · Phase 4 · not yet recruiting
- NCT07455981 — Work Organization and Gambling Addiction · not yet recruiting
- NCT07403500 — Evaluation of the Short-term Effectiveness of Spinal Manipulation to Treat Acute and Subacute Low Back Pain. · NA · not yet recruiting
- NCT07342010 — Bicarbonate Addition to Lidocaine-Epinephrine in Surgery Under WALANT · Phase 4 · not yet recruiting
- NCT07305727 — A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03437772 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nīmes
- Last refreshed: 4 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03437772.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing